Assessing the effects of probiotic supplementation in patients with metastatic melanoma on checkpoint-inhibitor therapy

被引：0
|
作者：
Vujevic, Andro [1 ]
Strikic, Dominik [1 ]
Plese, Sven [1 ]
Cegec, Ivana [1 ]
Turk, Viktorija Erdeljic [1 ]
Ausperger, Ksenija Makar [1 ]
Mikulic, Iva [1 ]
Aumiler, Matea Radacic [1 ]
Likic, Robert [1 ]
Mercep, Iveta [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0926
引用
收藏
页码：382 / 382
页数：1
相关论文
共 50 条
  • [21] Spontaneous coronary artery dissection (SCAD) under immune checkpoint-inhibitor therapy
    Spannbauer, A.
    Skoro-Sajer, N.
    Dona, C.
    Bartsch, R.
    Lamm, W.
    Gyoengyoesi, M.
    Lang, I
    Bergler-Klein, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S342 - S342
  • [22] RISK FACTORS FOR OUTCOMES OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS
    Voth, Elida
    Saha, Srishti
    Raffals, Laura
    Pardi, Darrell
    Khanna, Sahil
    GASTROENTEROLOGY, 2021, 160 (03) : S49 - S50
  • [23] Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma
    Gondois-Rey, Francoise
    Paul, Magali
    Alcaraz, Florence
    Bourass, Sarah
    Monnier, Jilliana
    Malissen, Nausicaa
    Grob, Jean-Jacques
    Bruger, Annika M.
    Van Der Bruggen, Pierre
    Gaudy-Marqueste, Caroline
    Olive, Daniel
    CANCERS, 2021, 13 (06) : 1 - 18
  • [24] Prognostic significance of von Willebrand factor concentration in patients with metastatic melanoma receiving immune checkpoint inhibitor therapy
    Mess, C.
    Stadler, J. C.
    Keller, L.
    Bauer, A. T.
    Koett, J.
    Geidel, G.
    Heidrich, I.
    Vidal-y-Sy, S.
    Andreas, A.
    Stramaglia, C.
    Sementsov, M.
    Haberstroh, W.
    Deitert, B.
    Hoehne, I. L.
    Reschke, R.
    Haalck, T.
    Pantel, K.
    Gebhardt, C.
    Schneider, S. W.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 18 - 18
  • [25] Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
    van de Donk, Pim P.
    Wind, Thijs T.
    Hooiveld-Noeken, Jahlisa S.
    van der Veen, Elly L.
    Glaudemans, Andor W. J. M.
    Diepstra, Arjan
    Jalving, Mathilde
    de Vries, Elisabeth G. E.
    de Vries, Erik F. J.
    Hospers, Geke A. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (13) : 4369 - 4376
  • [26] Autoimmune Encephalitis following Checkpoint Inhibitor Therapy in a Patient with Metastatic Melanoma in Complete Remission
    Civardi, Giuseppe
    Medioli, Alessia
    Braghieri, Carlotta
    Ambroggi, Massimo
    Immovilli, Paolo
    Orsucci, Simone
    Contini, Paolo
    Aronica, Giuseppe
    Cavanna, Luigi
    MEDICINA-LITHUANIA, 2024, 60 (05):
  • [27] Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000-2016
    Hellmund, Peter
    Schmitt, Jochen
    Roessler, Martin
    Meier, Friedegund
    Schoffer, Olaf
    CANCERS, 2020, 12 (09) : 1 - 17
  • [28] Nivolumab/Relatlimab: A Novel Addition to Immune Checkpoint Inhibitor Therapy in Unresectable or Metastatic Melanoma
    Phillips, Allison L.
    Reeves, David J.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (06) : 738 - 745
  • [29] Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
    Pim P. van de Donk
    Thijs T. Wind
    Jahlisa S. Hooiveld-Noeken
    Elly L. van der Veen
    Andor W. J. M. Glaudemans
    Arjan Diepstra
    Mathilde Jalving
    Elisabeth G. E. de Vries
    Erik F. J. de Vries
    Geke A. P. Hospers
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 4369 - 4376
  • [30] Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma
    Bossart, Simon
    Thurneysen, Selina
    Rushing, Elisabeth
    Frontzek, Karl
    Leske, Henning
    Mihic-Probst, Daniela
    Nagel, Hannes W.
    Mangana, Johanna
    Goldinger, Simone M.
    Dummer, Reinhard
    ONCOLOGIST, 2017, 22 (06) : 749 - 753
12345